| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 687005 | Null | 0.000184066440941432 | 0.44048492 |
| NSC 330507 | Tanespimycin | 0.00018474829680001 | 0.1966142 |
| NSC 332421 | 1,3-Dioxolo[4,5-g]quinolin-8-amine, N-1,3-benzodioxol-5-yl-6-methyl- | 0.000216242727122389 | 0.37424226 |
| NSC 36373 | Naphtho[2,3-d]-1,3-dioxole-6,7-dimethanol, 5,6,7,8-tetrahydro-5-hydroxy-8-(3,4,5-trimethoxyphenyl)-, higher melting isomer | 0.000216242727122389 | 0.21370297 |
| NSC 305802 | 2,4-Quinazolinediamine, 5,6,7,8-tetrahydro-6-(2-naphthalenylsulfonyl)- | 0.000281397700245213 | 0.43116022 |
| NSC 365798 | Fostamatinib disodium, Tamatinib fosdium | 0.000281397700245213 | 0.17181881 |
| NSC 668490 | Null | 0.000281397700245213 | -0.087663502 |
| NSC 720290 | Methyl-7.alpha.,12.alpha.-Diacetoxy-5.beta.-cholan-24-oate-3 -spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclohexane | 0.000285499812229894 | 0.28653621 |
| NSC 140380 | Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) | 0.000285499812229898 | 0.27634546 |
| NSC 631583 | Null | 0.000285499812229898 | 0.25398542 |